MCID: RCR004
MIFTS: 40

Recurrent Respiratory Papillomatosis malady

Categories: Rare diseases, Respiratory diseases

Aliases & Classifications for Recurrent Respiratory Papillomatosis

About this section
Sources:
45NIH Rare Diseases, 51Orphanet, 65UMLS, 37MESH via Orphanet, 66UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Recurrent Respiratory Papillomatosis:

Name: Recurrent Respiratory Papillomatosis 45 51 65
Juvenile-Onset Recurrent Respiratory Papillomatosis 45
Adult-Onset Recurrent Respiratory Papillomatosis 45
Respiratory Papillomatosis, Recurrent 45
Laryngeal Papilloma, Recurrent 45
 
Juvenile Laryngeal Papilloma 45
Jorrp 45
Aorrp 45
Rrp 45

Classifications:



External Ids:

Orphanet51 60032
MESH via Orphanet37 C535297
UMLS via Orphanet66 C1168198
UMLS65 C1168198

Summaries for Recurrent Respiratory Papillomatosis

About this section
NIH Rare Diseases:45 Recurrent respiratory papillomatosis (rrp) is a rare viral disease where tumors (papillomas) grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). although the tumors can grow anywhere in the respiratory tract, their presence in the larynx (voice box) causes the most frequent problems, a condition called laryngeal papillomatosis. the tumors may vary in size and grow very quickly. they often grow back even when removed. rrp is caused by two types of human papillomavirus (hpv), called hpv 6 and hpv 11. last updated: 11/21/2011

MalaCards based summary: Recurrent Respiratory Papillomatosis, also known as juvenile-onset recurrent respiratory papillomatosis, is related to psoriasis and systemic lupus erythematosus. An important gene associated with Recurrent Respiratory Papillomatosis is HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1), and among its related pathways are Staphylococcus aureus infection and CTLA4 Signaling. Affiliated tissues include lung, liver and breast, and related mouse phenotype respiratory system.

Related Diseases for Recurrent Respiratory Papillomatosis

About this section

Diseases related to Recurrent Respiratory Papillomatosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 316)
idRelated DiseaseScoreTop Affiliating Genes
1psoriasis30.6HLA-DQB1, HLA-DRB1
2systemic lupus erythematosus29.6HLA-DQB1, HLA-DRB1, IFNG
3laryngeal papillomatosis10.7
4leukemia10.5
5breast cancer10.5
6lymphoma10.4
7arthritis10.4
8rheumatoid arthritis10.4
9hepatitis10.4
10prostatitis10.4
11cervicitis10.4
12cerebritis10.4
13neuronitis10.4
14lichen planus pemphigoides10.3HLA-DQB1, HLA-DRB1
15tucker syndrome10.3HLA-DQB1, HLA-DRB1
16heavy chain deposition disease10.3HLA-DQB1, HLA-DRB1
17pulmonary coin lesion10.3HLA-DQB1, HLA-DRB1
18autoimmune polyglandular syndrome type 210.3HLA-DQB1, HLA-DRB1
19best1 retinopathy10.3HLA-DQB1, HLA-DRB1
20idiopathic juxtafoveal retinal telangiectasia10.3HLA-DQB1, HLA-DRB1
21lichtenstein syndrome10.3HLA-DQB1, HLA-DRB1
22actinomycosis10.3HLA-DQB1, HLA-DRB1
23finnish upper limb-onset distal myopathy10.3HLA-DQB1, HLA-DRB1
24metanephric adenoma10.3HLA-DQB1, HLA-DRB1
25nut allergy10.3HLA-DQB1, HLA-DRB1
26moderately severe hemophilia a10.3HLA-DQB1, HLA-DRB1
27angioid streaks10.3HLA-DQB1, HLA-DRB1
28prostate cancer10.3
29renal cell carcinoma10.3
30pancreatitis10.3
31adenoma10.3
32thyroiditis10.3
33aneurysm10.3
34hypertonia10.3HLA-DQB1, HLA-DRB1
35bipolar ll disorder10.3HLA-DQB1, HLA-DRB1
36bubonic plague10.3HLA-DQB1, HLA-DRB1
37vulvar benign neoplasm10.3EGFR, HLA-DRB1
38kernicterus due to isoimmunization10.3HLA-DQB1, HLA-DRB1
39ichthyosis-hypotrichosis-sclerosing cholangitis syndrome10.2HLA-DQB1, HLA-DRB1
40human spumaretrovirus infection10.2HLA-DQB1, HLA-DRB1
41artery disease10.2HLA-DQB1, HLA-DRB1
42rectal disease10.2HLA-DQB1, HLA-DRB1
43neuroblastoma10.2
44asthma10.2
45fibroma10.2
46sarcoma10.2
47clubfoot10.2
48cheilitis10.2
49melanoma10.2
50hyperinsulinism10.2

Graphical network of the top 20 diseases related to Recurrent Respiratory Papillomatosis:



Diseases related to recurrent respiratory papillomatosis

Symptoms for Recurrent Respiratory Papillomatosis

About this section

Drugs & Therapeutics for Recurrent Respiratory Papillomatosis

About this section

Drugs for Recurrent Respiratory Papillomatosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 25)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CidofovirapprovedPhase 4, Phase 2, Phase 131113852-37-260613
Synonyms:
(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine
(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
(S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine
(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid
(S)-HPMPC
(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
113852-37-2
120362-37-0 (hydrochloride salt)
149394-66-1
AC-1666
AC1L1TLB
AC1Q6C68
AKOS005145721
C8H14N3O6P
CDV
CHEBI:3696
 
CHEMBL152
CID60613
Cidofovir
Cidofovir (Vistide)
Cidofovir (anhydrous)
Cidofovir Anhydrous
Cidofovir anhydrous
Cidofovirum
DB00369
Forvade
GS 0504
GS 504
GS-0504
GS-504
GS504
HPMPC
HSDB 7115
LS-106432
MolPort-005-935-597
NSC742135
S1516_Selleck
UNII-768M1V522C
Vistide
Vistide, Cidofovir
[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
2Anti-Infective AgentsPhase 4, Phase 2, Phase 117220
3Contraceptives, OralPhase 4, Phase 23734
4Antiviral AgentsPhase 4, Phase 3, Phase 2, Phase 18071
5VaccinesPhase 3, Phase 06085
6AntibodiesPhase 34477
7ImmunoglobulinsPhase 34477
8Immunologic FactorsPhase 3, Phase 018483
9
Celecoxibapproved, investigationalPhase 2419169590-42-52662
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC-4228
AC1L1E6K
AI-525
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
CPD000550473
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
Célécoxib
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
KBio2_000912
 
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
MLS001165684
MLS001195656
MLS001304708
Medicoxib
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC-58635
SC58635
SMR000550473
SPBio_001512
SPECTRUM1503678
Solexa
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
Spectrum_000432
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM-177
YM177
ZINC02570895
cMAP_000027
celecoxib
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
10
Bevacizumabapproved, investigationalPhase 2, Phase 11875216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
11PembrolizumabapprovedPhase 22881374853-91-4
12
Vitamin Aapproved, nutraceuticalPhase 241311103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(2e,4e,6e,8e)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Chocola a
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A palmitate
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin a
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
13Angiogenesis InhibitorsPhase 2, Phase 13688
14Angiogenesis Modulating AgentsPhase 2, Phase 13611
15Peripheral Nervous System AgentsPhase 218510
16Antirheumatic AgentsPhase 28496
17Cyclooxygenase InhibitorsPhase 22225
18AnalgesicsPhase 29358
19Anti-Inflammatory AgentsPhase 28478
20Anti-Inflammatory Agents, Non-SteroidalPhase 23549
21Cyclooxygenase 2 InhibitorsPhase 2538
22Analgesics, Non-NarcoticPhase 25184
23Pharmaceutical SolutionsPhase 27004
24Retinol palmitatePhase 2413
25retinolNutraceuticalPhase 2413

Interventional clinical trials:

(show all 19)
idNameStatusNCT IDPhase
1Use of Cidofovir for Recurrent Respiratory PapillomatosisCompletedNCT00205374Phase 4
2Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")TerminatedNCT00747461Phase 4
3Effect of Vaccination in Patients With Recurrent Respiratory PapillomatosisActive, not recruitingNCT01375868Phase 3
44-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in ChildrenNot yet recruitingNCT01995721Phase 3
5Propranolol Administration in Pediatric Patients With Recurrent Respiratory PapillomatosisWithdrawnNCT01058317Phase 2, Phase 3
6A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory PapillomatosisCompletedNCT00038714Phase 2
7Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory PapillomatosisCompletedNCT00571701Phase 2
8Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory PapillomatosisRecruitingNCT02555800Phase 2
9Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary InvolvementRecruitingNCT02632344Phase 2
10New Therapy of Laryngeal Papilloma In ChildrenTerminatedNCT00591305Phase 2
11Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)CompletedNCT01020747Phase 1
12Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)CompletedNCT00001126Phase 1
13Optical Coherence Tomography of the Airway for Lung Cancer or Lung DiseaseWithdrawnNCT00733252Phase 1
14Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRPCompletedNCT00550914
15Human Papillomatosis Genotyping of Children in ThailandCompletedNCT01304966
16Human Papillomavirus 6/11 in the Lower Airway of NeonatesCompletedNCT00549250
17Recurrent Respiratory Papillomatosis and Extraesophageal RefluxRecruitingNCT02592902
18Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous LesionsRecruitingNCT02217358
19Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory PapillomatosisWithdrawnNCT00829608Phase 0

Search NIH Clinical Center for Recurrent Respiratory Papillomatosis

Genetic Tests for Recurrent Respiratory Papillomatosis

About this section

Anatomical Context for Recurrent Respiratory Papillomatosis

About this section

MalaCards organs/tissues related to Recurrent Respiratory Papillomatosis:

33
Lung, Liver, Breast, Prostate, Thyroid, Bone, T cells

Animal Models for Recurrent Respiratory Papillomatosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Recurrent Respiratory Papillomatosis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.6EGFR, FUT8, HLA-DQB1, IFNG

Publications for Recurrent Respiratory Papillomatosis

About this section

Articles related to Recurrent Respiratory Papillomatosis:

(show top 50)    (show all 351)
idTitleAuthorsYear
1
Reactivation of Immune Thrombocytopenia After Japanese Encephalitis Vaccination. (26457902)
2015
2
HES6 promotes prostate cancer aggressiveness independently of Notch signalling. (25864518)
2015
3
Heat shock protein 20 (HSPB6) regulates apoptosis in human hepatocellular carcinoma cells: Direct association with Bax. (24969689)
2014
4
Resistance training with instability in multiple system atrophy: a case report. (25177187)
2014
5
MUC1 and bcl-2 expression in preinvasive lesions and adenosquamous carcinoma of the lung. (23550464)
2013
6
Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptors. (24068707)
2013
7
Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice. (22498747)
2012
8
Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction. (20518849)
2011
9
Noonan syndrome gain-of-function mutations in NRAS cause zebrafish gastrulation defects. (21263000)
2011
10
A novel mutation in CACNA1A associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline. (21035146)
2011
11
Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. (19889614)
2010
12
Multiple desmoplastic melanomas in Birt-Hogg-DubAc syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibility. (21079084)
2010
13
Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1. (21318141)
2010
14
WaldenstrAPm macroglobulinemia with pseudo-Gaucher cells. (21089228)
2010
15
Glucocorticoid receptor gene polymorphism is less frequent in children born small for gestational age without catch-up growth. (19188741)
2009
16
Fatal Klebsiella pneumoniae meningitis and concomitant disseminated intravascular coagulation in a patient with diabetes mellitus. (19561976)
2009
17
Hyponatraemia after orthopaedic surgery - a case of pituitary apoplexy. (19335965)
2009
18
Promotion of reprogramming to ground state pluripotency by signal inhibition. (18942890)
2008
19
Oxygen breathing may be a cheaper and safer alternative to exogenous erythropoietin (EPO). (17493766)
2007
20
Portal vein embolization as a complication of Histoacryl injection for a bleeding giant gastric ulcer. (17440872)
2007
21
Calculation of binding energy using BLYP/MM for the HIV-1 integrase complexed with the S-1360 and two analogues. (17420131)
2007
22
Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis. (16459192)
2006
23
Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. (16740727)
2006
24
Is endometrial apoptosis evidence of endometrial aging in unexplained infertility? a preliminary report. (16054962)
2005
25
Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. (15357969)
2004
26
Stiff-person syndrome. (15140273)
2004
27
Practical synthesis of D- and l-2-cyclopentenone and their utility for the synthesis of carbocyclic antiviral nucleosides against orthopox viruses (smallpox, monkeypox, and cowpox virus). (14604375)
2003
28
Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade. (12354567)
2002
29
DNA sequence variation in a 3.7-kb noncoding sequence 5' of the CYP1A2 gene: implications for human population history and natural selection. (12181774)
2002
30
The Global Poliomyelitis Eradication Initiative: number of endemic countries at lowest ever. (12478998)
2002
31
Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study]. (11528553)
2001
32
Non-tropical thoraco-abdominal pyomyositis caused by group A streptococcus in an immunocompetent adult. (11760169)
2001
33
Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. (10869867)
2000
34
A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. (10836796)
2000
35
Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study]. (11234300)
2000
36
Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. (11073979)
2000
37
Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine. (10193676)
1999
38
Homozygous hemoglobin constant spring with normal electrophoresis. A possible cause for under-diagnosis. (9668571)
1998
39
Plasma membrane proteinases from lymphoid cells and their biological functions]. (9661785)
1998
40
The human biliary epithelial cell plasma membrane antigen in primary biliary cirrhosis: pyruvate dehydrogenase X? (9352878)
1997
41
Biochemistry of demyelination. (8864281)
1996
42
Failed treatment of pseudomyxoma peritonei (PMP) with intraperitoneal interferon alpha. (9005155)
1996
43
Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. (8634657)
1995
44
Regulation of activity levels of glycolipid sulfotransferases by transforming growth factor alpha in renal cell carcinoma cells. (7902207)
1993
45
Acidic fibroblast growth factor (aFGF) is present in the fluid of brain tumour pseudocysts. (1706557)
1990
46
Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. (2319404)
1990
47
Epithelial-myoepithelial carcinoma of the parotid gland. (3083342)
1986
48
Monocyte Fc-IgG receptors expression and soluble suppressor factor in skin squamous cell carcinoma. (6198840)
1983
49
GASTRIC TERATOMA IN AN ADULT: WITH A REVIEW OF THE LITERATURE. (14195959)
1964
50

Variations for Recurrent Respiratory Papillomatosis

About this section

Expression for genes affiliated with Recurrent Respiratory Papillomatosis

About this section
Search GEO for disease gene expression data for Recurrent Respiratory Papillomatosis.

Pathways for genes affiliated with Recurrent Respiratory Papillomatosis

About this section

Pathways related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

(show all 18)
idSuper pathwaysScoreTop Affiliating Genes
19.7HLA-DQB1, HLA-DRB1
29.7HLA-DQB1, HLA-DRB1
39.5HLA-DRB1, IFNG
49.5HLA-DRB1, IFNG
59.4EGFR, IFNG
69.4EGFR, IFNG
79.3IFNG, TAP1
8
Show member pathways
9.2EGFR, HLA-DQB1, HLA-DRB1
99.2HLA-DQB1, HLA-DRB1, TAP1
10
Show member pathways
9.1DPM1, FUT8
11
Show member pathways
9.1HLA-DQB1, HLA-DRB1, IFNG
129.1HLA-DQB1, HLA-DRB1, IFNG
13
Show member pathways
9.1HLA-DQB1, HLA-DRB1, IFNG
149.1HLA-DQB1, HLA-DRB1, IFNG
159.1HLA-DQB1, HLA-DRB1, IFNG
16
Show member pathways
8.6EGFR, HLA-DQB1, HLA-DRB1, IFNG
17
Show member pathways
8.5HLA-DQB1, HLA-DRB1, IFNG, TAP1
18
Show member pathways
8.5HLA-DQB1, HLA-DRB1, IFNG, TAP1

GO Terms for genes affiliated with Recurrent Respiratory Papillomatosis

About this section

Cellular components related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1trans-Golgi network membraneGO:00325889.7HLA-DQB1, HLA-DRB1
2ER to Golgi transport vesicle membraneGO:00125079.4HLA-DQB1, HLA-DRB1

Biological processes related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1immunoglobulin production involved in immunoglobulin mediated immune responseGO:000238110.2HLA-DQB1, HLA-DRB1
2adaptive immune responseGO:00022509.3IFNG, TAP1
3antigen processing and presentationGO:00198829.2HLA-DQB1, HLA-DRB1, IFNG

Sources for Recurrent Respiratory Papillomatosis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet